Robert Philibert - Oct 25, 2022 Form 3 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Role
Chief Medical Officer, Director, 10%+ Owner
Signature
/s/ Elisa Luqman - Attorney-in-Fact for Robert Philibert and BD Holding Inc.
Stock symbol
CDIO
Transactions as of
Oct 25, 2022
Transactions value $
$0
Form type
3
Date filed
11/4/2022, 01:31 PM
Next filing
Jun 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDIO Common Stock 7.6K Oct 25, 2022 Direct
holding CDIO Common Stock 1.59M Oct 25, 2022 See Note 1 F1
holding CDIO Common Stock 14.1K Oct 25, 2022 See Note 2 F2
holding CDIO Common Stock 7.6K Oct 25, 2022 See Note 3 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDIO Stock Options (right to buy) Oct 25, 2022 Common Stock 514K $3.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held directly by BD Holding Inc. ("BD Holding"). Dr. Philibert may be deemed to beneficially own these securities because he is the sole director and officer, and the controlling shareholder, of BD Holding. He disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2 These securities are held directly by a limited liability company of which Dr. Philibert is the control person. He may be deemed to beneficially own these securities because he is the control person of such company. He disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F3 These securities are held by Dr. Philibert's spouse. Dr. Philibert disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Remarks:

The reporting persons are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended.